IO Biotech Inc
NASDAQ:IOBT

Watchlist Manager
IO Biotech Inc Logo
IO Biotech Inc
NASDAQ:IOBT
Watchlist
Price: 1.45 USD 1.4% Market Closed
Market Cap: 95.5m USD

Relative Value

There is not enough data to reliably calculate the relative value of IOBT.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IOBT Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.3
vs History
vs Industry
Median 3Y
-1
Median 5Y
-1
Industry
23.3
Forward
-1
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.2
Industry
19.8
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.2
Industry
22.6
vs History
2
vs Industry
61
Median 3Y
0.8
Median 5Y
0.8
Industry
2.7
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
7.6
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
30
Median 3Y
0.4
Median 5Y
0.3
Industry
4.7
Forward
-0.6
vs History
vs Industry
28
Median 3Y
0.4
Median 5Y
0.3
Industry
4.8
Forward
-0.6
vs History
vs Industry
31
Median 3Y
0.5
Median 5Y
0.4
Industry
5.3
vs History
vs Industry
27
Median 3Y
0.5
Median 5Y
0.4
Industry
3.8
vs History
2
vs Industry
Median 3Y
-6.4
Median 5Y
-4.8
Industry
5

Multiples Across Competitors

IOBT Competitors Multiples
IO Biotech Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
DK
IO Biotech Inc
NASDAQ:IOBT
95.5m USD 0 -1 -0.6 -0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 841 650.5 -160 844.3 -195 316.3 -193 087.6
US
Abbvie Inc
NYSE:ABBV
335.2B USD 5.8 80.7 15.3 22.7
US
Amgen Inc
NASDAQ:AMGN
159.7B USD 4.7 26.9 14.4 23.8
US
Gilead Sciences Inc
NASDAQ:GILD
138.3B USD 4.8 23.2 10.1 13.9
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.8B USD 10.8 -121.2 25.8 27
US
Epizyme Inc
F:EPE
94.1B EUR 2 081.7 -531.2 -578.4 -563
AU
CSL Ltd
ASX:CSL
118.6B AUD 5.1 28.2 17.4 21.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.3B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.5 -66.3 -59.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
41.4B USD 17.6 -153.4 -687.8 -344.7
P/S Multiple
Revenue Growth P/S to Growth
DK
IO Biotech Inc
NASDAQ:IOBT
Average P/S: 3 384 380.5
Not Available
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
33 841 650.5
N/A N/A
US
Abbvie Inc
NYSE:ABBV
5.8
8%
0.7
US
Amgen Inc
NASDAQ:AMGN
4.7
4%
1.2
US
Gilead Sciences Inc
NASDAQ:GILD
4.8
3%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
10.8
10%
1.1
US
E
Epizyme Inc
F:EPE
2 081.7
N/A N/A
AU
CSL Ltd
ASX:CSL
5.1
7%
0.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
4.2
4%
1.1
US
S
Seagen Inc
F:SGT
20.1
30%
0.7
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
17.6
29%
0.6
P/E Multiple
Earnings Growth PEG
DK
IO Biotech Inc
NASDAQ:IOBT
Average P/E: 34.4
Negative Multiple: -1
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 844.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.7
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.9
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.2
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -121.2 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -531.2 N/A N/A
AU
CSL Ltd
ASX:CSL
28.2
16%
1.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.5 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -153.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
DK
IO Biotech Inc
NASDAQ:IOBT
Average EV/EBITDA: 15.8
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -195 316.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.4
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -578.4 N/A N/A
AU
CSL Ltd
ASX:CSL
17.4
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -687.8 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
DK
IO Biotech Inc
NASDAQ:IOBT
Average EV/EBIT: 20.4
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -193 087.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.7
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.8
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.9
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
27
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563 N/A N/A
AU
CSL Ltd
ASX:CSL
21.7
14%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -344.7 N/A N/A